Efficacy and Safety of Pregabalin in Treatment of Neuropathic Pain in Patients With Idiopathic Small Fiber Neuropathy
Status:
Completed
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess safety and efficacy of treatment with pregabalin in
patients with idiopathic small fiber neuropathy proven by skin biopsy.This is an enriched
enrollment randomized withdrawal study that comprises 4 phases: a screening and selection
phase, a washout period from previous pain medication for enriched enrollment, an 8 week
single blind pregabalin treatment phase; and a 4 week randomized withdrawal phase.